Panbela Starts Phase II Trial of CPP-1X-T for Recent Onset Type I Diabetes, in Collaboration with Indiana University School of Medicine and JDRF
Stock Information for Panbela Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.